Quit and Screen Project

NCT ID: NCT06350643

Last Updated: 2026-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-02-15

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases.

The goal of this clinical trial is to test the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This clinical trial tests the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition.

In partnership with the National Medical Association, investigators will recruit 300 healthcare providers who provide clinical services to individuals who smoke smoke. Interested providers will be screened; if eligible, the will complete informed consent. Providers who complete the online consent and agree to enroll in the training study will be individually randomized to one of 2 conditions: The Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training. After randomization, providers will complete a pre-test assessing their knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography. Providers will then complete an online training. Providers will then complete a post-test assessing their 1) knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography and 2) preferences for the online materials and satisfaction with the training. Feasibility will be assessed using data on provider interest in the training and training reach.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knowledge Attitudes Behavioral Intention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Quit and Screen Project training alone

Providers in this arm will only complete the Quit and Screen Project training. This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training .

Group Type EXPERIMENTAL

Quit and Screen Project training

Intervention Type OTHER

This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training.

Quit and Screen Project training + G02 Lung Cancer Screening training

In this arm, providers will complete the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training and the Quit and Screen Project training. The Quit and Screen Project training is an online course being developed to fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 Lung Cancer Screening training.

Group Type EXPERIMENTAL

Quit and Screen Project training

Intervention Type OTHER

This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training.

G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training

Intervention Type OTHER

The G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training is an online course that covers disparities in lung cancer and smoking, patient barriers to lung cancer screening, and provider resources for addressing common barriers.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Quit and Screen Project training

This online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training.

Intervention Type OTHER

G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training

The G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training is an online course that covers disparities in lung cancer and smoking, patient barriers to lung cancer screening, and provider resources for addressing common barriers.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current National Medical Association (NMA) member
* Serves a patient clientele who smokes
* At least 20% of time (1 day per week) devoted to clinical care
* Currently screens clients for tobacco use in the clinic
* Have the capacity to refer smokers to a patient navigator
* Willing to provide informed consent
* Will provide contact email, address and phone.

Exclusion Criteria

* None
Minimum Eligible Age

21 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Virginia Commonwealth University

OTHER

Sponsor Role collaborator

Coalition for a Tobacco Free Arkansas

UNKNOWN

Sponsor Role collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

Sponsor Role collaborator

National Medical Association

UNKNOWN

Sponsor Role collaborator

University of Arkansas

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pebbles Fagan, PhD, MPH

Role: PRINCIPAL_INVESTIGATOR

University of Arkansas

Mignonne Guy, PhD

Role: PRINCIPAL_INVESTIGATOR

Virginia Commonwealth University

Ashley Clawson, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Arkansas

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Virginia Commonwealth Univesity

Richmond, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mignonne Guy, PhD

Role: CONTACT

804-828-1731

Ashley Clawson, PhD

Role: CONTACT

501-526-6413

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mignonne Guy, PhD

Role: primary

804-828-1731

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P50MD017319-03S1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

287064

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Goal2Quit + NRT Sampling
NCT03837379 COMPLETED NA
Smartphone Based Smoking Cessation Intervention
NCT03740490 COMPLETED PHASE2/PHASE3
Helping Poor Smokers Quit
NCT03194958 COMPLETED NA
Improving Quitline Support Study
NCT03538938 COMPLETED PHASE4
The Get Quit - Stay Quit Study
NCT01980485 COMPLETED NA
Smoking Cessation Intervention
NCT03072511 TERMINATED PHASE4
Not Quite Ready to Quit
NCT01866722 COMPLETED NA